UWASH CALCIUM-CHANNEL BLOCKER STUDY SUPPORTS JNC V APPROACH TO HYPERTENSION; CCB COMPANIES CONTEST FINDING OF INCREASED RISK v. BETA BLOCKERS, DIURETICS
A meeting of the National High Blood Pressure Education Program Coordinating Committee March 20 in Washington, D.C., will provide a likely forum for discussion of a University of Washington case-control study of antihypertensives.
You may also be interested in...
Pharma companies need to consider an obligation to complete ongoing clinical trials when entering into merger agreements, an editorial published in The Journal of the American Medical Association argues
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011